MELINTA THERAPEUTICS

melinta-therapeutics-logo

Melinta Therapeutics is an antibiotics-focused company. The companyโ€™s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, whic... h is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). In addition, Melinta is focused on its ongoing research program to develop a new class of antibiotics designed to overcome the resistant ESKAPE pathogens known to cause the majority of serious hospital infections and patient deaths. Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners and Warburg Pincus.

#SimilarOrganizations #People #Financial #Event #Website #More

MELINTA THERAPEUTICS

Social Links:

Industry:
Biotechnology Emergency Medicine Health Care Pharmaceutical

Founded:
2000-01-01

Address:
New Haven, Connecticut, United States

Country:
United States

Website Url:
http://www.melinta.com

Total Employee:
251+

Status:
Active

Contact:
(203) 624-5606

Email Addresses:
[email protected]

Total Funding:
877.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Apache


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

atlas-venture-logo

Atlas Venture

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

xeris-pharmaceuticals-logo

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.


Current Advisors List

not_available_image

Erik Akhund Board Member @ Melinta Therapeutics
Board_member
2014-01-01

not_available_image

Thomas Koestler Chairman of the Board of Directors @ Melinta Therapeutics
Board_member
2012-01-01

christopher-p-kiritsy_image

Christopher P. Kiritsy Board of Directors @ Melinta Therapeutics
Board_member

sundar-kodiyalam_image

Sundar Kodiyalam Board of Directors @ Melinta Therapeutics
Board_member

not_available_image

Erik Akhund Board of Directors @ Melinta Therapeutics
Board_member

zack-scott_image

Zack Scott Board Observer @ Melinta Therapeutics
Board_observer

Current Employees Featured

erin-duffy_image

Erin Duffy
Erin Duffy Chief Scientific Officer @ Melinta Therapeutics
Chief Scientific Officer

peter-moore_image

Peter Moore
Peter Moore Scientific Founders @ Melinta Therapeutics
Scientific Founders

thomas-steitz_image

Thomas Steitz
Thomas Steitz Scientific Founders @ Melinta Therapeutics
Scientific Founders

doug-girgenti_image

Doug Girgenti
Doug Girgenti Vice President of Drug Development @ Melinta Therapeutics
Vice President of Drug Development
2021-10-01

matthew-balogh_image

Matthew Balogh
Matthew Balogh Head Of Digital Marketing @ Melinta Therapeutics
Head Of Digital Marketing
2020-11-01

pete-piliero_image

Pete Piliero
Pete Piliero Vice President of Medical Affairs @ Melinta Therapeutics
Vice President of Medical Affairs
2022-03-01

dan-wechsler_image

Dan Wechsler
Dan Wechsler President & Chief Executive Officer @ Melinta Therapeutics
President & Chief Executive Officer

peter-diroma_image

Peter DiRoma
Peter DiRoma Vice President Regulatory Affairs and Quality Assurance @ Melinta Therapeutics
Vice President Regulatory Affairs and Quality Assurance
2014-06-01

william-jorgensen_image

William Jorgensen
William Jorgensen Scientific Founders @ Melinta Therapeutics
Scientific Founders

Founder


harry-h-penner_image

Harry H. Penner

not_available_image

Harry Noller

peter-moore_image

Peter Moore

thomas-steitz_image

Thomas Steitz

william-jorgensen_image

William Jorgensen

Stock Details


Company's stock symbol is NASDAQ:MLNT

Acquisitions List

Date Company Article Price
2020-06-09 Tetraphase Pharmaceuticals Tetraphase Pharmaceuticals acquired by Melinta Therapeutics N/A
2017-11-29 The Medicines Company - Infectious Disease Care The Medicines Company - Infectious Disease Care acquired by Melinta Therapeutics 270 M USD

Investors List

carb-x_image

CARB-X

CARB-X investment in Grant - Melinta Therapeutics

deerfield_image

Deerfield

Deerfield investment in Post-IPO Debt - Melinta Therapeutics

oberland-capital_image

Oberland Capital

Oberland Capital investment in Post-IPO Equity - Melinta Therapeutics

malin-corporation-plc_image

Malin Corporation

Malin Corporation investment in Post-IPO Equity - Melinta Therapeutics

vatera-healthcare-partners_image

Vatera Healthcare Partners

Vatera Healthcare Partners investment in Post-IPO Equity - Melinta Therapeutics

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Melinta Therapeutics

falcon-flight-2_image

Falcon Flight

Falcon Flight investment in Post-IPO Equity - Melinta Therapeutics

vatera-healthcare-partners_image

Vatera Healthcare Partners

Vatera Healthcare Partners investment in Post-IPO Equity - Melinta Therapeutics

abs-ventures_image

ABS Ventures

ABS Ventures investment in Post-IPO Equity - Melinta Therapeutics

vox-equity-partners-i_image

Vox Equity Partners I

Vox Equity Partners I investment in Post-IPO Equity - Melinta Therapeutics

Official Site Inspections

http://www.melinta.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.72 K

  • Host name: 23.96.252.42
  • IP address: 23.96.252.42
  • Location: Chicago United States
  • Latitude: 41.8483
  • Longitude: -87.6517
  • Metro Code: 602
  • Timezone: America/Chicago
  • Postal: 60602

Loading ...

More informations about "Melinta Therapeutics" on Search Engine